Navigation Links
AllergyEasy® Announces No-shots Immunotherapy to Mitigate Dust Allergies
Date:7/28/2014

Mesa, AZ (PRWEB) July 28, 2014

For those with dust allergies, home can be a miserable place. Dust mites—a prime cause of dust allergies—commonly settle in mattresses, bedding, and upholstered furniture and elicit allergic reactions including hay fever and asthma.

Dust mites are microscopic insects that feed on the dead skin of pets and humans. Most people shed enough skin each day to keep a million dust mites fat and happy. When a speck of dust is examined under a high power microscope, the decaying bodies and feces of dust mites can be seen.  It is the proteins found in this dust mite "debris" that cause allergic reactions.

Dust mites are most prevalent in July and August because they thrive in warm, humid temperatures. There are a number of steps that the public can take to limit exposure to dust mites such as laundering bedding once a week at high temperatures, encasing mattresses, box springs and pillows in allergen-proof covers, changing furnace filters regularly using high-efficiency particulate air filters, vacuuming frequently, and keeping the moisture in your home low with a dehumidifier. More cautious steps include replacing curtains or blinds with wooden shutters and installing hard flooring in place of carpet.    

While these measures can be helpful, Dr. Stuart Agren, director of a national network of allergy clinics known as AllergyEasy, said that he often sees patients who have spent a lot of money on avoidance measures without seeing a return on their investment.

"You can buy all of the anti-allergen filters and bedding covers, but the fact is, dust is everywhere!" said Dr. Agren.

Agren recommends that patients seek out allergy testing and treatment when dust allergies are affecting their quality of life.

Allergy treatment can "train" the body to stop having allergic reactions to dust particles in the first place. Dust particles are, after all, harmless.  However, when an allergic person encounters them, the immune system mistakenly perceives them as "enemy invaders" and tries to fend them off by releasing chemicals such as histamine into the body. This chemical defense causes a litany of common allergic reactions including itchy eyes, sneezing, nasal congestion, coughing, wheezing, asthma, and more. 

Allergy treatment begins with an allergy serum that helps patients build up an immunity to common allergens (including dust mite proteins) and stop overreacting to them.

Allergy treatment is commonly available through allergy shots or oral allergy drops. Dr. Agren said that many patients are now gravitating to allergy drops because they are safer and more convenient. 

"Because the drops don't have the same risk of anaphylactic reaction associated with shots, they can be taken in the comfort of home rather than at the physician's office," said Dr. Agren. "Given the pace of today's living, this seems to be much easier for people to do on a regular basis." 

For more information on AllergyEasy's treatment options, visit http://www.AllergyEasy.com or call them at 480-827-0038 extension.

AllergyEasy
2033 E Warner Road, Suite 102
Tempe, AZ 85284

Read the full story at http://www.prweb.com/releases/allergy/immunotherapy/prweb12050002.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. AFAR announces the 2012 Hartford Centers of Excellence in Geriatric Medicine awards
2. Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder
3. University of Houston Graduate College of Social Work announces partnership with MD Anderson
4. The Ludwig Institute for Cancer Research announces launch of iTeos Therapeutics SA
5. AGA announces prestigious awards recognition recipients
6. TheBestHeartRateMonitorReviews.com Announces The Top 3 Heart Rate Monitors
7. Article Marketing Company Content Writing King Announces Training Of New Graphic Design Artist
8. Zane Benefits Announces Wellness HRAs: A New Way to Reward Healthy Employees
9. San Francisco’s Advanced Male Medical Center Announces Discount, Discusses Erectile Dysfunction
10. Insulite Labs announces the launch of the PCOS Inspiration Hour, a one hour virtual gathering place for women with PCOS and other women’s health issues to come together.
11. NYC Doc Announces 3 Surprising Ways to Beat Seasonal Allergies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... and Shelton, CT (PRWEB) , ... May 02, 2016 , ... ... President and Owner of New England Low Vision and Blindness (NELV&B) , announces ... add more flexibility and convenience for people with vision impairments to get assessments, hands-on ...
(Date:5/1/2016)... ... May 01, 2016 , ... ... that gives new mothers a better understanding of what to expect after they ... Adjusting to baby postpartum, · The blues and depression, · Breastfeeding beyond postpartum ...
(Date:4/30/2016)... ... April 30, 2016 , ... Create ... Abstract users can distort and manipulate three-dimensional shapes with ease all within ... ranks, point, lines, polygons, polygon texture animation, opacity texture animation, overall shape texture ...
(Date:4/30/2016)... , ... April 30, 2016 ... ... CBC News on April 4th, 2016 questioned the use of the HyProCure ... EOTTS-HyProCure as “a controversial procedure.” EOTTS-HyProCure is a minimally invasive procedure performed, ...
(Date:4/29/2016)... ... April 29, 2016 , ... In an article published ... her enthusiasm for Botox and lip injections, which she underwent in order to feel ... Valley Music and Arts Festival. The article explains that Ms. Mirmelli’s situation is not ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... April 28, 2016 New ... 2016" is a report that provides an overview ... R&D pipelines by identifying new targets and MOAs ... Company Profiles discussed in this H1 2016 Osteoarthritis ... Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx NV, ...
(Date:4/27/2016)... BASEL , Schweiz, April 27, 2016 ... des Sachs CEO Forums in Zürich ... Phase-II-Studie ihres führenden Wirkstoffkandidaten STR001 zur Erhaltung ... (CI) eingesetzt wurde, bekannt. Für die umfassende ... Deutschland und Frankreich angeworben. STR001 wird während ...
(Date:4/27/2016)... 2016   , ... Recurring Consumable Sales  Clinical sales grow 16% ... (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... the first quarter ended March 31, 2016 and provided ... its commercial strategy. First Quarter 2016 Revenue ...
Breaking Medicine Technology: